University of Pennsylvania
Dr. Stanley Schwartz is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago. Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment. In the past 7 years he has been a CME speaker in Turks/Caicos, Istanbul, Switzerland , Belgium, Tunisia ,Spain , 11 cities in China, Phillipines x4 (AACE, Phillipine Endo. Societyx2, China Hospital ), Israel, Singapore, Korea , and Ireland, and AACE 2011/2014, ADA 2014-2015. He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials (DCCT-EDIC, LOOK AHEAD). He has created a call for minimizing hypoglycemia ( predicting a ~50% in hospitals using incretins, and minimizing insulin use in â€˜Type 2 â€˜ DM. He has proposed a New Classification and Unified Pathophysiologic Construct for All Diabetes and presented it in Jerusalem, at ADA 2014 and ADA/JDRF symposium 2015 and now published in Diabetes Care, and Trends in Endocrinology. Since leaving Penn, he has received an R-01 from the NIH for studying the Genes related to LADA (with 2 articles published), written 3 book chapters, had posters at 2012 AACE, ADA and EASD in 2014 and 2015), has had 28 peerreviewed articleâ€™s published (incretins in Hospital , hypoglycemia, a critique of ADA DM guideline , incretins in NODAT , weight reduction in DM, the incretin story), and most recently A Unified Pathophysiologic Construct of DM and its Complications.. He is an author of the Self-Assessment Program of the American Diabetes Assoc (2007 and 2008) , the 2009/2010 AACE Diabetes Guidelines, and slide modules for primary care for AACE, 2011 and 2013, and Diabetes in Control 2013-2017 . He is a member or fellow of international, national, and local professional societies including an Overseas Fellow of the Royal Society of Medicine (London), European Association for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), the American Diabetes Association (ADA), the American Endocrine Society (ES), College of Physicians in Philadelphia, and the American College of Physicians (ACP). Heâ€™s been elected by his peers for inclusion in Best Doctors in AmericaÂ® from 1996 to 2017. Though he does some research and teaches a great deal, most of his time is spent caring for patients .